Paradiem, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Paradiem, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$680.49 - $826.97 $217,756 - $264,630	320 Added 9.55%	3,670 $3.02 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $198,355 - $215,355	-281 Reduced 7.74%	3,350 $0
Q3 2022 Oct 18, 2022	BUY	$573.97 - $724.32 $2.08 Million - $2.63 Million	3,631 New	3,631 $2.5 Million
Q1 2021 May 18, 2021	SELL	$446.73 - $548.2 $1.48 Million - $1.82 Million	-3,313 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$478.3 - $607.98 $1.58 Million - $2.01 Million	3,313 New	3,313 $1.71 Million

1,516

82.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Paradiem, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradiem, LLC with notifications on news.